TONG REN TANG TECHNOLOGIES CO. LTD. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.91 HKD | +1.87% |
|
+4.03% | -25.04% |
| Mar. 22 | Tong Ren Tang Technologies Co. Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Mar. 05 | China Permits Clinical Trial of Tong Ren Teng's Anti-Blood Stasis Drug | MT |
Evolution of the average Target Price on Tong Ren Tang Technologies Co. Ltd.
Price target over the last 5 years
History of analyst recommendation changes
c69f511d5a98f68dbe71e02dcf7c8e.XbnATSuv5-rzpJsVMGa04IgJ4uvlSCPnrLvlIa6TlgI.L8OJLmLkg628z_gneFH8tsVdjKCHIlKy_M6LRd3J2FMq07AHfu6hp8D1-A~c28ed2a6e5bacbfc86526ef3b74dcb51
Analysts' Consensus
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
4.459
CNY
Average target price
6.058
CNY
Spread / Average Target
+35.85%
High Price Target
6.477
CNY
Spread / Highest target
+45.25%
Low Price Target
5.638
CNY
Spread / Lowest Target
+26.44%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
B-
EPS Revisions
Annual profits - Rate of surprise
- Stock Market
- Equities
- 1666 Stock
- Consensus Tong Ren Tang Technologies Co. Ltd.
